EYE nationalvision.com: Narxning prognoz qilingan daromadga nisbati

America's Best Contacts & Eyeglasses (EYE) tovar belgisi

Xodimlar va ijara xarajatlari tufayli jismoniy tarmoqni kengaytirishning qiyinligi National Vision Holdings (EYE) kotirovkalariga bosim o'tkazmoqda. Forward P/S baholashiga ko'ra, 0.50 baza parametr qiymati bo'lib xizmat qiladigan narx dinamikasi namoyon bo'lmoqda. Kompaniyaning fundamental ko'rsatkichlari onlayn raqobat va yirik shartnomalarning yo'qolishi tufayli zaiflashgan, biroq shaxsiy klinikalar rivojlantirish va raqamlashtirish orqali amalga oshirilayotgan joriy operatsion o'zgarishlar biznes modelini barqarorlashtirishi kerak.

National Vision - EYE Forvard P/S multiplikatori (davr: 04.07.2022 - 17.11.2026)

National Vision (EYE) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- bozor narxi va tahlilchilarning maqsadli narxlari:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
Kompaniyaning jamlanma tahliliyoti:America's Best Contacts & Eyeglasses EYE
nationalvision.com tomonidan chiqariladigan mahsulotlar

National Vision Holdings (EYE) kompaniyasida optometriya va linzalarni ichki ishlab chiqarishning integratsiyasi sezilarli biznes qiymatini yaratadi, bu esa 0.50 forward P/S koeffitsiyentida aks etgan. Ushbu ko'rsatkich bozor kapitalizatsiyasini kutilayotgan daromad bilan solishtiradi, bu esa investorlarga aktiv haddan tashqari sotib olinganini yoki ekotizim kengayishining joriy sur'ati davom etgan taqdirda narx o'sishi uchun imkoniyat mavjudligini baholash imkonini beradi.

Raqobatdosh kompaniyalar tahlili

Forvard P/S multiplikatori HCA (HCA Healthcare, Inc.)|Narxning kutilayotgan daromadga nisbati THC (Tenet Healthcare)|FMS - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati solventum.com|EHC: Forvard P/S multiplikatori|UHS - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|DVA (DaVita Corp) - Forvard P/S multiplikatori|RDNT: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori OPCH|SGRY (surgerypartners.com) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori PINC (Premier Inc)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Progyny Inc (PGNY)|Ardent Health - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Select Medical Corp SEM|ASTH: Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati MD|USPH (US Physical Therapy Inc) - Forvard P/S multiplikatori|PNTG: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Organogenesis Corp (ORGO)|NUTX (Nutex Health Corp) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori AUNA (Auna S.A.)|SBC Medical Group Holdings Inc (SBC) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|EOLS - Narxning prognoz qilingan daromadga nisbati|Sotuvga nisbatan forvard narx CYH (Community Health Systems Inc)|SKIN (beautyhealth.com) - Forvard narx/daromad multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati MDWD|Narxning prognoz qilingan daromadga nisbati biote Corp.|Bozor kapitallashuvining kelajakdagi daromadga nisbati thejoint.com JYNT|Forvard P/S multiplikatori DCGO|Forvard narx/daromad multiplikatori P3 Health PIII|Forvard P/S multiplikatori GANX (Gain Therapeutics Inc.)|Forvard P/S multiplikatori EUDA Health Holdings Limited EUDA|baselmedical.com - Forvard P/S multiplikatori|CLGN: Narxning prognoz qilingan daromadga nisbati|Cuprina Holdings (Cayman) Ltd. (CUPR) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori Concord Medical|AMS (American Shared Hospital Services Inc) - Forvard P/S multiplikatori|MEDIROM Corp (MRM) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard P/S multiplikatori ALBT|Kapitalizatsiyaning kutilayotgan sotuvga nisbati DIH Holding|Forvard P/S multiplikatori XAGE (carmellcosmetics.com)|NIVF: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|ATIP: Forvard narx/daromad multiplikatori|CareMax Medical Group - Narxning kutilayotgan daromadga nisbati|Kindly MD (KDLY) - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning prognoz qilingan daromadga nisbati MODV|Narxning prognoz qilingan daromadga nisbati Novo Integrated Sciences Corp|Bozor kapitallashuvining kelajakdagi daromadga nisbati SunLink Health Systems SSY|Narxning prognoz qilingan daromadga nisbati IMAC Corp (BACK)